TERRACCIANO, Luigi Maria
 Distribuzione geografica
Continente #
NA - Nord America 8.678
AS - Asia 5.466
EU - Europa 1.544
SA - Sud America 1.019
AF - Africa 315
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 2
Totale 17.039
Nazione #
US - Stati Uniti d'America 8.521
SG - Singapore 3.648
BR - Brasile 859
CN - Cina 777
VN - Vietnam 524
FI - Finlandia 320
IE - Irlanda 246
NG - Nigeria 211
IT - Italia 200
DE - Germania 173
FR - Francia 162
HK - Hong Kong 118
GB - Regno Unito 113
CA - Canada 90
IN - India 89
NL - Olanda 79
AR - Argentina 58
BD - Bangladesh 51
SE - Svezia 46
MX - Messico 42
TR - Turchia 31
ZA - Sudafrica 31
PL - Polonia 30
RU - Federazione Russa 26
IQ - Iraq 25
BE - Belgio 24
UA - Ucraina 24
EC - Ecuador 23
JP - Giappone 23
ID - Indonesia 21
CZ - Repubblica Ceca 18
ES - Italia 18
VE - Venezuela 18
CL - Cile 16
PK - Pakistan 16
IL - Israele 15
PH - Filippine 15
KE - Kenya 14
UZ - Uzbekistan 13
CO - Colombia 12
MA - Marocco 12
SA - Arabia Saudita 12
UY - Uruguay 12
PY - Paraguay 11
EG - Egitto 10
JO - Giordania 10
RO - Romania 10
TN - Tunisia 10
AU - Australia 9
AE - Emirati Arabi Uniti 8
AL - Albania 8
AT - Austria 8
DZ - Algeria 8
NP - Nepal 8
TH - Thailandia 8
BO - Bolivia 7
BY - Bielorussia 6
LT - Lituania 6
RS - Serbia 6
CR - Costa Rica 5
ET - Etiopia 5
IR - Iran 5
NZ - Nuova Zelanda 5
PS - Palestinian Territory 5
AZ - Azerbaigian 4
BG - Bulgaria 4
BH - Bahrain 4
KG - Kirghizistan 4
KR - Corea 4
KZ - Kazakistan 4
MY - Malesia 4
PA - Panama 4
TT - Trinidad e Tobago 4
AO - Angola 3
EE - Estonia 3
JM - Giamaica 3
PE - Perù 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CH - Svizzera 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
KH - Cambogia 2
KW - Kuwait 2
LB - Libano 2
NO - Norvegia 2
OM - Oman 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BW - Botswana 1
BZ - Belize 1
CD - Congo 1
CV - Capo Verde 1
CY - Cipro 1
Totale 17.020
Città #
Singapore 1.685
Chandler 1.284
Wilmington 1.208
Ashburn 527
San Mateo 517
Dallas 497
The Dalles 496
Shanghai 405
San Jose 330
Helsinki 319
Ann Arbor 294
Dublin 245
Boardman 228
Lawrence 211
Princeton 211
Benin City 210
Beijing 200
Leawood 196
New York 175
Ho Chi Minh City 164
Hanoi 130
Paris 128
Fairfield 122
Hong Kong 110
Woodbridge 91
Milan 77
Los Angeles 76
São Paulo 70
Amsterdam 65
London 54
Seattle 48
Santa Clara 47
Toronto 45
San Diego 39
Falkenstein 32
Rio de Janeiro 27
Haiphong 25
Warsaw 25
Norwalk 24
Da Nang 23
Orem 23
Phoenix 23
Brussels 20
Council Bluffs 20
Johannesburg 19
Chennai 18
Tokyo 18
Belo Horizonte 17
Brooklyn 17
Brasília 16
Montreal 16
Frankfurt am Main 15
Buffalo 14
Campinas 14
Porto Alegre 14
Atlanta 13
Pune 13
Abbiategrasso 12
Brno 12
Caxias do Sul 12
Mexico City 12
Nairobi 12
Biên Hòa 11
Curitiba 11
Dhaka 11
Munich 11
Naples 11
Redmond 11
Stockholm 11
Tashkent 11
Boston 10
Hillsboro 10
Montevideo 10
Poplar 10
Denver 9
Kocaeli 9
Manchester 9
Sumaré 9
Amman 8
Fortaleza 8
Guayaquil 8
Kyiv 8
Quito 8
Reston 8
Ribeirão Preto 8
San Francisco 8
Sorocaba 8
Thái Bình 8
Ankara 7
Baghdad 7
Bangkok 7
Can Tho 7
Chicago 7
Columbus 7
Guarulhos 7
Houston 7
Jeddah 7
Manaus 7
Rome 7
Asunción 6
Totale 11.337
Nome #
Biomarker testing implementation for molecularly targeted therapy in non-small cell lung cancer patients 384
SH2D4A is frequently downregulated in hepatocellular carcinoma and cirrhotic nodules 185
AMACR expression in colorectal cancer is associated with left-sided tumor localization 110
Prognostic value of alpha-methyl CoA racemase (AMACR) expression in renal cell carcinoma. 105
Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis 102
Amplification of 8q21 in breast cancer is independent of MYC and associated with poor patient outcome. 100
Adaptive regulation of the ileal apical sodium dependent bile acid transporter (ASBT) in patients with obstructive cholestasis 100
Amplification of SKI is a prognostic marker in early colorectal cancer 98
Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis 98
Digital analysis of intratumoural heterogeneity reveals higher leucocytic infiltrate in VETC (Vessels Encapsulating Tumour Clusters) areas 97
High expression of HOXA13 correlates with poorly differentiated hepatocellular carcinomas and modulates sorafenib response in in vitro models 95
ABCG5-positivity in tumor buds is an indicator of poor prognosis in node-negative colorectal cancer patients. 95
Local recurrence in mismatch repair-proficient colon cancer predicted by an infiltrative tumor border and lack of CD8+ tumor-infiltrating lymphocytes 94
MAGE-A10 is a nuclear protein frequently expressed in high percentages of tumor cells in lung, skin and urothelial malignancies. 92
Autoimmune hepatitis 92
Y chromosome loss is a frequent early event in urothelial bladder cancer. 92
PS-24-008 Prevalence of vessels encapsulating tumour clusters (VETC) in human cancers 91
Antitumor effects of OSU-2S, a nonimmunosuppressive analogue of FTY720, in hepatocellular carcinoma. 91
Human aldehyde oxidase 1 interacts with ATP-binding cassette transporter-1 and modulates its activity in hepatocytes 88
Effect of EpCAM, CD44, CD133 and CD166 expression on patient survival in tumours of the ampulla of Vater. 88
Chromosomal alterations in hepatocellular nodules by comparative genomic hybridization: high-grade dysplastic nodules represent early stages of hepatocellular carcinoma 88
Liver precancerous lesions and hepatocellular carcinoma: the histology report. 88
Bioptic diagnosis of chronic hepatitis. Results of an evidence-based consensus conference of the German Society of Pathology, of the German Society for Digestive and Metabolic Diseases and of Compensated Hepatitis (HepNet) 88
Two-marker protein profile predicts poor prognosis in patients with early rectal cancer 87
CD44 variant isoforms control experimental autoimmune encephalomyelitis by affecting the lifespan of the pathogenic T cells 87
Interferon-Induced Gene Expression Is a Stronger Predictor of Treatment Re-sponse Than IL28B Genotype in Patients With Hepatitis C. 86
Identifying and targeting ROS1 gene fusions in non-small cell lung cancer 86
Characterization of rectal, proximal and distal colon cancers based on clinico-pathological, molecular and protein profiles. 86
Overexpression of the receptor for hyaluronic acid mediated motility is an independent adverse prognostic factor in colorectal cancer 85
Disruption of Notch1 Induces Vascular Remodeling, Intussusceptive Angio-genesis, and Angiosarcomas in Livers of Mice. 85
Autoimmune hepatitis: overlap syndromes 85
Increased MET Gene Copy Number Negatively Affects Survival of Surgically Resected Non-Small-Cell Lung Cancer Patients 84
A novel pT1 substaging system for high-grade urothelial bladder carcinoma: a prospective mono-institutional confirmatory progression risk analysis 83
HMGA1 and HMGA2 protein expression correlates with advanced tumour grade and lymph node metastasis in pancreatic adenocarcinoma 83
Toxicity of valproic acid in mice with decreased plasma and tissue carnitine stores 82
HER2, TOP2A, CCND1, EGFR, And C-MYC oncogene amplification in colorectal cancer 82
Clinicopathological and protein characterization of BRAF and K-RAS mutated colorectal cancer and implications for prognosis. 82
AXIN2+ Pericentral Hepatocytes Have Limited Contributions to Liver Homeostasis and Regeneration 82
Immunophenotyping and oncogene amplifications in tumors of the papilla of Vater 81
Cystic lymphangioma associated with enteric duplication as a cause of recurrent vomiting 80
Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues : a tissue microarray analysis on 4,387 tissue samples 80
Predicting Fibrosis Worsening in Obese Patients With NASH Through Paren-chymal Fibronectin, HOMA-IR, and Hypertension. 80
Expression of CEACAM6 in resectable colorectal cancer: a factor of independent prognostic significance 80
Changes of the hepatic proteome in hepatitis B-infected mouse model at early stages of fibrosis 80
Proliferation, but not growth, blocked by conditional deletion of 40S ribosomal protein S6 79
Prognostic value of cell cycle and apoptosis regulatory proteins in mismatch repair-proficient colorectal cancer: a tissue microarray-based approach 78
Are the Mallory bodies and intracellular hyaline bodies in neoplastic and non-neoplastic hepatocytes related? 78
Case Report: Unclassified Renal Cell Carcinoma With Medullary Phenotype and SMARCB1/INI1 Deficiency, Broadening the Spectrum of Medullary Carcinoma 78
Role of APAF-1, E-cadherin and peritumoral lymphocytic infiltration in tumour budding in colorectal cancer 77
High incidence of EMMPRIN expression in human tumors 77
Mechanisms of venoocclusive disease resulting from the combination of cyclophosphamide and roxithromycin 77
Abstract Chronic hepatitis C in childhood: an 18-year experience 77
The HOX gene network in hepatocellular carcinoma 77
Interferon signaling and treatment outcome in chronic hepatitis C 76
Galectin-1 and its involvement in hepatocellular carcinoma aggressiveness. 76
Interleukin 6 is important for survival after partial hepatectomy in mice 76
Characterization of the immunological microenvironment of tumour buds and its impact on prognosis in mismatch repair-proficient and -deficient colorectal cancers. 76
World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Prebiotics 76
Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression 75
p16 expression in oropharyngeal cancer: its impact on staging and prognosis compared with the conventional clinical staging parameters. 75
Hepatitis with Fibrin-Ring Granulomas 74
Expression of hepatitis c virus proteins inhibits interferon alpha signaling in the liver of transgenic mice 74
S-adenosyl-methionine and betaine improve early virological response in chronic hepatitis C patients with previous nonresponse. 74
The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas 74
Enzyme histochemical diagnosis of gastrointestinal motility disorders. A laboratory guide 73
Epidermal growth factor receptor protein expression and genomic alterations in renal cell carcinoma. 73
Childhood Dietary Intake in Italy: The Epidemiological "MY FOOD DIARY" Survey 73
Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers 73
Loss of raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer 73
The loss of the CBX7 gene expression represents an adverse prognostic marker for survival of colon carcinoma patients. 73
Fatal liver failure in an adult patient with acute lymphoblastic leukemia following treatment with L-asparaginase 72
Inducible inactivation of Notch1 causes nodular regenerative hyperplasia in mice 72
Expression and functional role of a transcribed noncoding RNA with an ultra-conserved element in hepatocellular carcinoma. 72
Cytogenetic alterations in liver cell tumors as detected by comparative genomic hybridization 71
Prognostic significance of mucins in colorectal cancer with different DNA mismatch-repair status 71
Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer 71
The HOX genes are expressed, in vivo, in human tooth germs: in vitro cAMP exposure of dental pulp cells results in parallel HOX network activation and neuronal differentiation 71
Virus-induced over-expression of protein phosphatase 2A inhibits insulin signalling in chronic hepatitis C 71
Chromosomal instability in gastric mucosa-associated lymphoid tissue lymphomas: a fluorescent in situ hybridization study using a tissue microarray approach 71
Glypican-3 expression in primary and recurrent ovarian carcinomas 71
Validation of an Extension of the International Non-Invasive Criteria for the Diagnosis of Hepatocellular Carcinoma to the Characterisation of Macroscopic Portal Vein Thrombosis. 71
Patterns of liver infiltration in lymphoproliferative disease 71
Role of the mitogen-activated protein kinase and phosphoinositide 3-kinase/AKT pathways downstream molecules, phosphorylated extracellular signal-regulated kinase, and phosphorylated AKT in colorectal cancer-a tissue microarray-based approach 71
MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients 70
Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: a tissue microarray analysis of 4,387 tissue samples 70
Loss of APAF-1 expression is associated with tumour progression and adverse prognosis in colorectal cancer 70
Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I. 70
Downregulation of renal endothelin-converting enzyme 2 expression in early autoimmune diabetes 70
Fibrolamellar hepatocellular carcinoma occurring 5 years after hepatocellular adenoma in a 14-year-old girl: a case report with comparative genomic hybridization analysis 70
Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients 70
Tenascin-W is a novel marker for activated tumor stroma in low-grade human breast cancer and influences cell behavior 70
TIA-1 cytotoxic granule-associated RNA binding protein improves the prognostic performance of CD8 in mismatch repair-proficient colorectal can-cer. 69
A simple and reproducible scoring system for EGFR in colorectal cancer: application to prognosis and prediction of response to preoperative brachytherapy 69
Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies 69
Observational Study of PD-L1, TGF-β, and Immune Cell Infiltrates in Hepatocellular Carcinoma 69
Intratumoral Switch of Molecular Phenotype and Overall Survival in Muscle Invasive Bladder Cancer 68
Enzyme histochemistry of classical and ultrashort Hirschsprung's disease 68
Role of the VEGF ligand to receptor ratio in the progression of mismatch re-pair-proficient colorectal cancer. 68
Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer 68
Prognostic and predictive relevance of DNAM-1, SOCS6 and CADH-7 genes on chromosome 18q in colorectal cancer 67
Totale 8.370
Categoria #
all - tutte 109.373
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.373


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021564 0 0 0 0 0 0 0 0 0 305 4 255
2021/2022938 26 9 13 270 4 13 26 160 77 30 241 69
2022/20233.336 460 124 341 354 328 311 16 279 577 268 234 44
2023/20241.674 130 175 348 62 64 172 71 123 32 28 161 308
2024/20252.822 68 30 35 56 48 281 117 337 377 639 419 415
2025/20266.276 1.067 358 539 657 161 277 2.105 426 352 334 0 0
Totale 17.328